In summary, normal O‐GlcNAcylation levels may have a protective effect in ALS, whereas its downregulation promotes multiple key pathological processes—including NF assembly, TDP‐43 aggregation, and NPGPx‐mediated oxidative stress—thereby driving ALS progression. The gene discussed is GPX7; the disease is amyotrophic lateral sclerosis.